This was after stating that it is 'hard to find a better place in the world' to do science. The announcement follows that of GlaxoSmithKline regarding plans to invest £275million in its UK manufacturing plants.
The announcement by these big pharma companies of their commitment to remain in the UK comes at a time when reassurance is much needed as to the future of pharma in the UK after the Brexit vote.